Abstract
Background
Psychological, emotional, and mental distress affects many patients who experience early pregnancy loss (EPL). A common concern is that the patient’s actions or choices caused the loss. Understanding the cause of EPL may improve the distress of EPL patients and their partners. Chromosomal abnormalities leading to a significant portion of EPL. Cell-free DNA (cfDNA) testing, a non-invasive test providing high quality information about the chromosomal makeup of a fetus, may offer assurance that a fetal abnormality caused the loss, and provide more certainty or closure in processing EPL. CfDNA may be a useful adjunct to patient-centered care in the setting of EPL. This commentary explores the possibility of cfDNA testing in lessening the emotional distress that often accompanies EPL.
Methods
The peer reviewed literature was explored for manuscripts addressing (1) the potential for cfDNA serum testing for patients experiencing EPL and screening products of conception to determine the cause of EPL; and/or (2) the impact that information might have on the psychological morbidity of EPL for patients and their partners. Themes generated from extracted data were used to generate key questions for future research.
Results
Preliminary findings suggest fetal fraction values are instrumental in the success of cfDNA testing, and a successful cfDNA testing experience can have a positive impact on patients.
Conclusions
Ultimately, we conclude cfDNA testing could have a positive impact in patient care and improve the well-being of patients undergoing the emotional toll of EPL by reducing feelings of guilt and providing closure to those who learn the loss was associated with chromosomal abnormality. Further trials and studies that explore the intersection of mental health of EPL on patients should explore the efficacy of cfDNA testing as an adjunct to patient-centered care in these cases.
Similar content being viewed by others
References
SanLazaroCampillo I, Meaney S, McNamara K, O’Donoghue K. Psychological and support interventions to reduce levels of stress, anxiety, or depression on women’s subsequent pregnancy with a history of miscarriage: an empty systematic review. BMJ Open. 2017;7(9):e017802. https://doi.org/10.1136/bmjopen-2017-017802.
Clark-Ganheart, Cecily A. MD; Fries, Melissa H. MD; Leifheit, Kathryn M. MSPH; Jensen, Taylor J. PhD; Moreno-Ruiz, Nilda L. MD, MPH; Ye, Peggy P. MD, MPH; Jennings, Jacky M. PhD, MPH; Driggers, Rita W. MD Use of cell-free DNA in the investigation of intrauterine fetal demise and miscarriage. Obstet Gynecol. 2015; 125(6):1321–1329. https://doi.org/10.1097/AOG.0000000000000863
Warburton D, Cytogenetics of reproductive wastage: from conception to birth. Med Cytogenet. 2000; 235–268 CRC Press
den VanBerg MMJ, Dancet EAF, Erlikh T, van derVeen F, Goddijn M, Hajenius PJ. Patient-centered early pregnancy care: a systematic review of quantitative and qualitative studies on the perspectives of women and their partners. Hum Reprod Updat. 2018;24(1):106–18. https://doi.org/10.1093/humupd/dmx030.
Farren J, Jalmbrant M, Ameye L, Joash K, Mitchell-Jones N, Tapp S, et al. Post-traumatic stress, anxiety, and depression following miscarriage or ectopic pregnancy: a prospective cohort study. BMJ Open. 2016;6(11):e011864.
Farren J, Mitchell-Jones N, Verbakel JY, Timmerman D, Jalmbrant M, Bourne T. The psychological impact of early pregnancy loss. Hum Reprod Update. 2018;24(6):731–49. https://doi.org/10.1093/humupd/dmy025.
Colley E, Devall AJ, Williams H, Hamilton S, Smith P, Morgan NV, Quenby S, Coomarasamy A, Allen S. Cell-free DNA in the investigation of miscarriage. J Clin Med. 2020;9(11):3428.
Yaron Y, Pauta M, Badenas C, Soler A, Borobio V, Illanes C, Paz-Y-Miño F, Martinez-Portilla R, Borrell A. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup. Hum Reprod. 2020;35(5):1222–9. https://doi.org/10.1093/humrep/deaa073.
Yaron, Yuval and Pauta, Montse and Badenas, Celia and Soler, Anna and Borobio, Virginia and Illanes, Carmen and Martinez-Portilla, Raigam and Paz-y-Miño, Fernanda and Borrell, Antoni, Maternal serum genome-wide cell-free DNA testing detects fetal aneuploidy in early and recurrent pregnancy loss (September 15, 2019). Available at SSRN: https://ssrn.com/abstract=3452103 or https://doi.org/10.2139/ssrn.3452103.
Farren J, Jalmbrant M, Falconieri N, Mitchell-Jones N, Bobdiwala S, Al-Memar M, Tapp S, Van Calster B, Wynants L, Timmerman D, Bourne T. Differences in post-traumatic stress, anxiety and depression following miscarriage or ectopic pregnancy between women and their partners: multicenter prospective cohort study. Ultrasound Obstet Gynecol. 2021;57(1):141–8. https://doi.org/10.1002/uog.23147.
Peng S, Bhatt S, Borrell A, Yaron Y. Economic impact of using maternal plasma cell‐free DNA testing to guide further workup in recurrent pregnancy loss. Prenat Diagn. 2021; First published 2021. https://doi.org/10.1002/pd.5972.
Talati AN, Gilmore KL, Hardisty EE, et al. Impact of prenatal exome sequencing for fetal genetic diagnosis on maternal psychological outcomes and decisional conflict in a prospective cohort. Genet Med. 2021;23:713–9. https://doi.org/10.1038/s41436-020-01025-5.
Nynas J, Narang P, Kolikonda MK, Lippmann S. Depression and anxiety following early pregnancy loss: recommendations for primary care providers. Prim Care Companion CNS Disord. 2015;17(1). https://doi.org/10.4088/PCC.14r01721.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zayyad, S., Liang, R., Winkel, A.F. et al. Can cell-free DNA (cfDNA) testing alleviate psychological distress in early miscarriage? A commentary. J Assist Reprod Genet 39, 1219–1224 (2022). https://doi.org/10.1007/s10815-022-02489-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-022-02489-x